Novartis, UPenn get breakthrough for CAR therapy

Novartis AG (NYSE:NVS; SIX:NOVN) and partner University of Pennsylvania said FDA granted breakthrough therapy designation for CTL019 to treat relapsed/refractory adult and pediatric acute lymphoblasti...